Development Level

Tclin 9 | 613
Tbio 6 | 11,445
Tchem 2 | 1,598

IMPC Phenotype

preweaning lethality, complete... 4 | 979
abnormal behavioral response t... 2 | 66
decreased total body fat amoun... 2 | 207
decreased anxiety-related resp... 1 | 12
decreased fasted circulating g... 1 | 65
decreased large unstained cell... 1 | 11
decreased lean body mass 1 | 135
decreased neutrophil cell numb... 1 | 42
impaired righting response 1 | 26
increased circulating chloride... 1 | 41
increased circulating sodium l... 1 | 71
increased circulating total pr... 1 | 28
increased lean body mass 1 | 172
increased lymphocyte cell numb... 1 | 32
increased total body fat amoun... 1 | 134
preweaning lethality, incomple... 1 | 499
prolonged QT interval 1 | 38
prolonged ST segment 1 | 36

Disease

Carcinoma 12 | 11,493
Hypertension 11 | 396
Major Depressive Disorder 9 | 301
Schizophrenia 8 | 1,160
malignant mesothelioma 8 | 3,232
Breast cancer 7 | 3,578
Cancer 7 | 2,499
Hypertensive disease 7 | 292
Hypotension 7 | 82
lung cancer 7 | 4,740
Autistic Disorder 6 | 364
Bipolar Disorder 6 | 666
Heart disease 6 | 306
Migraine 6 | 83
Pain 6 | 103
Pulmonary hypertension 6 | 85
Unipolar Depression 6 | 250
invasive ductal carcinoma 6 | 2,951
lung adenocarcinoma 6 | 2,716
medulloblastoma, large-cell 6 | 6,241
non-small cell lung cancer 6 | 2,890
osteosarcoma 6 | 7,950
psoriasis 6 | 6,694
ulcerative colitis 6 | 1,819
Alcohol dependence 5 | 107
Autosomal recessive predisposition 5 | 1,442
Bradycardia 5 | 36
Depressive disorder 5 | 409
Heart failure 5 | 162
Mood Disorders 5 | 184
diabetes mellitus 5 | 1,728
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,955
Alcoholic Intoxication, Chronic 4 | 289
Constipation 4 | 181
Hypertension, Pulmonary 4 | 37
Kidney disease 4 | 430
Memory Disorders 4 | 40
Mental Depression 4 | 333
Obesity 4 | 678
Substance abuse 4 | 59
breast carcinoma 4 | 1,638
colon cancer 4 | 1,478
ependymoma 4 | 4,679
group 3 medulloblastoma 4 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
lung carcinoma 4 | 2,843
obsessive-compulsive disorder 4 | 61
ovarian cancer 4 | 8,520
pulmonary arterial hypertension 4 | 75
Acute kidney injury 3 | 70
Alzheimer's disease 3 | 658
Amnestic disorder 3 | 35
Anhedonia 3 | 27
Astrocytoma, Pilocytic 3 | 3,081
Attention deficit hyperactivity disorder 3 | 278
Broad flat nasal bridge 3 | 236
Cardiac Arrhythmia 3 | 103
Cardiomegaly 3 | 116
Cardiomyopathies 3 | 110
Cerebrovascular disease 3 | 238
Cocaine Dependence 3 | 51
Cocaine-Related Disorders 3 | 92
Diabetes Mellitus, Non-Insulin-Dependent 3 | 145
Diabetes Mellitus, Type 2 3 | 142
Diaphragmatic Hernia 3 | 40
Diarrhea 3 | 253
Generalized anxiety disorder 3 | 29
Hernia, Diaphragmatic 3 | 40
Hyperalgesia 3 | 83
Intestinal Obstruction 3 | 31
Irritable bowel syndrome 3 | 60
Lung disease 3 | 142
Motion sickness 3 | 21
Nasal bridge wide 3 | 236
Nausea and vomiting 3 | 97
Parkinson's disease 3 | 392
Personality disorder 3 | 25
Portal hypertension 3 | 20
Premature ejaculation 3 | 16
Sexual dysfunction 3 | 9
Sudden infant death syndrome 3 | 32
Weight decreased 3 | 103
adult high grade glioma 3 | 3,801
ductal carcinoma in situ 3 | 1,745
glioblastoma 3 | 5,792
hypopigmented skin patch 3 | 59
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
pancreatic cancer 3 | 2,398
primary pancreatic ductal adenocarcinoma 3 | 1,109
Breast Neoplasms 2 | 445
Congenital Heart Defects 2 | 58
Congenital deafness 2 | 185
Deafness 2 | 198
Depression, Postpartum 2 | 7
Fever 2 | 138
Hearing Loss, Partial 2 | 185
Mammary Neoplasms 2 | 425
X-linked cerebral adrenoleukodystrophy 2 | 116
facioscapulohumeral dystrophy 2 | 288
hearing impairment 2 | 199

Tissue

Endocrine System 17 | 18,159
Blood and immune system 16 | 16,909
Skin and soft tissues 16 | 17,230
Urinary Tract 16 | 16,678
Digestive Tract 15 | 17,369
Female tissues 15 | 17,400
Liver and Pancreas 15 | 16,750
Male tissues 15 | 17,142
Nervous System 15 | 16,725
Respiratory system 15 | 16,393
Cardiovascular System 12 | 15,192

Target Family

GPCR 8 | 408
Non-IDG 5 | 12,091
Ion Channel 2 | 344
Enzyme 1 | 4,145
Transporter 1 | 473

GO Process

vasoconstriction 17 | 17
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
5-hydroxytryptamine receptor 2B HTR2B Tclin GPCR -2.66641 486.3 265
Endothelin-3 EDN3 Tbio Non-IDG -2.96371 794.0 219
5-hydroxytryptamine receptor 1A HTR1A Tclin GPCR -3.67718 4891.4 254
Endothelin-2 EDN2 Tbio Non-IDG -2.65568 390.3 131
5-hydroxytryptamine receptor 7 HTR7 Tclin GPCR -4.15964 13643.7 259
Transient receptor potential cation channel subfamily M member 4 TRPM4 Tchem Ion Channel -2.19653 160.9 186
5-hydroxytryptamine receptor 1D HTR1D Tclin GPCR -2.54328 350.8 140
5-hydroxytryptamine receptor 1B HTR1B Tclin GPCR -3.03042 1068.4 211
Endothelin-1 receptor EDNRA Tclin GPCR -2.86513 644.6 259
Endothelin receptor type B EDNRB Tclin GPCR -3.27771 1756.7 324